Dosing chart / Growth hormone

Ipamorelin vs Sermorelin

Dose, schedule, route and approval status side by side.

IpamorelinSermorelin
StatusNot approvedNot approved
Also known as–Geref
Typical dose100–300 mcg200–500 mcg
How oftenDaily, 1–3 timesDaily, at bedtime
ScheduleOne to three times daily, commonly before bed.Once daily at bedtime.
Daily equivalent100–900 mcg/day200–500 mcg/day
RouteSubcutaneousSubcutaneous
Duration8–12 weeks reported3–6 months reported
NotesGrowth hormone secretagogue. Reached Phase 2 for post-surgical bowel recovery but was not approved.Formerly FDA-approved for childhood growth hormone deficiency; the brand was discontinued commercially, not for safety reasons. Now supplied through compounding pharmacies.

This page sets the two chart entries next to each other. It does not say which is better or whether either is right for you. Read member experiences on the Ipamorelin and Sermorelin pages.

Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.